Name | Number of supported studies | Average coverage | |
---|---|---|---|
GABAergic neuron | 3 studies | 21% ± 4% | |
glutamatergic neuron | 3 studies | 28% ± 3% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 3 studies | 21% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 930.65 | 1445 / 1445 | 100% | 3.78 | 183 / 183 |
uterus | 100% | 1066.07 | 170 / 170 | 100% | 5.69 | 457 / 459 |
breast | 100% | 1047.83 | 459 / 459 | 100% | 3.80 | 1113 / 1118 |
bladder | 100% | 902.43 | 21 / 21 | 99% | 3.19 | 501 / 504 |
prostate | 100% | 1179.06 | 245 / 245 | 99% | 2.70 | 497 / 502 |
skin | 100% | 1118.48 | 1809 / 1809 | 99% | 4.46 | 467 / 472 |
intestine | 100% | 1144.57 | 966 / 966 | 98% | 2.81 | 517 / 527 |
stomach | 100% | 742.62 | 359 / 359 | 98% | 2.77 | 280 / 286 |
thymus | 100% | 1149.91 | 653 / 653 | 97% | 2.71 | 589 / 605 |
lung | 100% | 958.78 | 578 / 578 | 97% | 3.29 | 1124 / 1155 |
ovary | 100% | 1023.21 | 180 / 180 | 97% | 4.45 | 417 / 430 |
pancreas | 100% | 531.71 | 328 / 328 | 97% | 2.42 | 172 / 178 |
brain | 97% | 562.42 | 2552 / 2642 | 99% | 3.09 | 696 / 705 |
kidney | 100% | 640.93 | 89 / 89 | 84% | 1.76 | 761 / 901 |
adrenal gland | 100% | 798.17 | 258 / 258 | 73% | 1.23 | 167 / 230 |
liver | 100% | 517.72 | 226 / 226 | 68% | 1.77 | 277 / 406 |
adipose | 100% | 910.23 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 20.52 | 29 / 29 |
spleen | 100% | 1811.97 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 6.62 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 4.27 | 1 / 1 |
blood vessel | 100% | 806.51 | 1334 / 1335 | 0% | 0 | 0 / 0 |
muscle | 100% | 988.60 | 802 / 803 | 0% | 0 | 0 / 0 |
heart | 98% | 501.54 | 846 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 90% | 2.26 | 72 / 80 |
peripheral blood | 83% | 845.79 | 773 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0043409 | Biological process | negative regulation of MAPK cascade |
GO_0032259 | Biological process | methylation |
GO_2000035 | Biological process | regulation of stem cell division |
GO_0090263 | Biological process | positive regulation of canonical Wnt signaling pathway |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0016604 | Cellular component | nuclear body |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_1990841 | Molecular function | promoter-specific chromatin binding |
GO_0001228 | Molecular function | DNA-binding transcription activator activity, RNA polymerase II-specific |
GO_0046872 | Molecular function | metal ion binding |
GO_0008168 | Molecular function | methyltransferase activity |
Gene name | PRDM15 |
Protein name | PR/SET domain 15 PR domain zinc finger protein 15 (EC 2.1.1.-) (PR domain-containing protein 15) (Zinc finger protein 298) PRDM15 protein PR/SET domain 15 (Zinc finger protein ZNF298d) |
Synonyms | ZNF298 C21orf83 |
Description | FUNCTION: Sequence-specific DNA-binding transcriptional regulator. Plays a role as a molecular node in a transcriptional network regulating embryonic development and cell fate decision. Stimulates the expression of upstream key transcriptional activators and repressors of the Wnt/beta-catenin and MAPK/ERK pathways, respectively, that are essential for naive pluripotency and self-renewal maintenance of embryonic stem cells (ESCs). Specifically promotes SPRY1 and RSPO1 transcription activation through recognition and direct binding of a specific DNA sequence in their promoter regions. Involved in early embryo development (By similarity). Also plays a role in induced pluripotent stem cells (iPSCs) reprogramming . . |
Accessions | ENST00000398548.6 ENST00000422911.6 E7ER26 ENST00000441787.5 ENST00000491486.5 Q4W8S1 Q6NXF8 ENST00000447016.6 A0A6Q8PFK1 P57071 ENST00000269844.5 ENST00000449395.6 |